John Parselle

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

NaturalMotion Ltd. engages in software solutions and tools. It provides social mobile publisher on IOS and android for games applications. The company was founded on October 15, 2001 and is headquartered in Oxford, The United Kingdom.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers.

Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies.

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue.

Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom.

Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.

Helio Display Materials Ltd. engages in research and experimental development on natural sciences and engineering. The company was founded on November 28, 2016 and is headquartered in London, the United Kingdom.

Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA.

Part of Accroma Labtec AG, LabMinds, Inc. is a leader in AI and robotics for solution preparation in pharmaceutical and life science labs. The company is based in Somerville, MA. LabMinds' platform addresses the challenges of solution preparation with powerful AI software combined with state-of-the-art robotics to safeguard against tainted inputs, enable near-perfect accuracy, and attain unmatched control. The company was founded in 2008 by Camilla Lisa Oxley, Ville Juhani Lehtonen, Jochen Wilhelm Klingelhoefer, Andrew David Hunt. LabMinds was acquired by Accroma Labtec AG on December 13, 2022.

Iothic Ltd. develops machine learning and artificial intelligence applications. The British company was founded in 2017 by Christopher Autry. Christopher Autry has been the CEO since 2017.